Metabolomics and Detection of Colorectal Cancer in Humans: A Systematic Review

Future Oncology - Tập 6 Số 9 - Trang 1395-1406 - 2010
Haili Wang1, Victor Tso1, Carolyn M. Slupsky2, Richard N. Fedorak1
1University of Alberta, Room #L-10B Zeidler Ledcor Centre, 130 University Campus, 112th St & 85th Avenue, Edmonton, AB T6G 2X8, Canada.
2University of California Davis CA USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1155/2004/983459

10.1038/ajg.2009.104

Ramsoekh D , van LeerdamME, van BallegooijenM, HabbemaJDF, KuipersEJ: Population screening for colorectal cancer: faeces, endoscopes or x-rays?Cell. Oncol.23(3), 185–194 (2007).

10.1111/j.1440-1746.2004.03177.x

Wang H , SlupskyC, SawyerM, WongC, SchillerD, FedorakR: The role of NMR urine metabolomics as a new method for screening colorectal cancer – a preliminary analysis.Can. J. Gastroenterol.23(Suppl. A) (2009) (Abstract 144).

10.1200/JCO.2006.09.7550

10.1016/j.tibtech.2004.03.007

10.1038/sj.mp.4002000

Broadhurst DI , BrownM, DunnWBet al.: The application of UPLC/LTQ-Orbitrap mass spectrometry to human metabolite biomarker discovery. A case study: pre-eclampsia.Reprod. Sci.15(2), 208A–208A (2008).

Siffedeen JS , RankinKN, FuH, DielemanLA, SlupskyC, FedorakR: Metabolomics in inflammatory bowel disease: differentiating patients with or without IBD.Gastroenterology134(4), A203–A203 (2008).

10.1016/j.ab.2007.01.028

10.1586/14737159.7.4.329

10.1146/annurev.pharmtox.48.113006.094715

10.1186/1471-2288-3-25

Ma Y QinH LiuWet al.: Ultra-high performance liquid chromatography-mass spectrometry for the metabolomic analysis of urine in colorectal cancer.Dig. Dis. Sci.1–8 (2008).

10.1021/pr8006232

Piotto M MoussalliehF DillmannBet al.: Metabolic characterization of primary human colorectal cancers using high resolution magic angle spinning 1 H magnetic resonance spectroscopy.Metabolomics1–10 (2008).

10.1186/1476-4598-7-72

10.1002/mrm.1910300502

10.1021/pr9004162

10.1021/pr901081y

10.1186/1741-7015-8-13

10.1002/nbm.1345

10.1002/nbm.1372

10.1016/j.trac.2004.11.021

10.1021/pr0605217

10.1093/toxsci/kfi102

10.1007/s10549-006-9400-z

10.1016/j.aca.2008.04.048

10.1080/13547500802012858

10.1016/j.pnmrs.2005.09.001

10.1177/153303460400300609

10.1158/0008-5472.CAN-04-4106

10.1186/1471-230X-7-39

10.1111/j.1572-0241.2004.30623.x

10.1111/j.1572-0241.2007.01217.x

10.1016/j.phrs.2004.01.006

10.1586/14737159.6.2.135

10.1186/1476-4598-7-33

10.1021/pr0702565

10.11569/wcjd.v16.i1.68